Baseline Patient Characteristics (n = 140)
| Characteristic | Data |
| Median age (y) | 59 (range, 17–85) |
| Age > 60 y | 64 (46%) |
| Female sex | 56 (39%) |
| Histologic type | |
| PTCL-NOS | 35 (25%) |
| AITL | 54 (38%) |
| ALK-negative ALCL | 29 (21%) |
| ALK-positive ALCL | 22 (16%) |
| Ann Arbor stage III–IV | 121 (86%) |
| ECOG 2–3 | 42 (30%) |
| IPI > 2 | 68 (49%) |
| PIT > 1* | 65 (46%) |
| Bone marrow biopsy involved* | 33 (24%) |
| Increased serum LDH | 74 (52%) |
| Consolidative transplantation | 32 (23%) |
| TMTV > 230 cm3 | 65 (46%) |
↵* 136 patients with bone marrow biopsy data available.
LDH = lactate dehydrogenase.
Data are number followed by percentage in parentheses, except for median age.